Clinical trials
Venous Thromboembolism trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
117 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 3 |
| 2003 | 1 |
| 2004 | 3 |
| 2005 | 2 |
| 2006 | 7 |
| 2007 | 7 |
| 2008 | 11 |
| 2009 | 5 |
| 2010 | 4 |
| 2011 | 6 |
| 2012 | 5 |
| 2013 | 5 |
| 2014 | 7 |
| 2015 | 6 |
| 2016 | 6 |
| 2017 | 7 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 3 |
| 2021 | 7 |
| 2022 | 5 |
| 2023 | 2 |
| 2024 | 5 |
| 2025 | 2 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 85 |
| Terminated | 14 |
| Recruiting | 10 |
| Unknown status | 5 |
| Not yet recruiting | 2 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ottawa Hospital Research Institute | 21 |
| Bayer | 14 |
| McMaster University | 14 |
| Boehringer Ingelheim | 8 |
| Sanofi | 8 |
| Hamilton Health Sciences Corporation | 6 |
| Daiichi Sankyo | 5 |
| University of Calgary | 5 |
| Regeneron Pharmaceuticals | 3 |
| Anthos Therapeutics, Inc. | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Venous Thromboembolism | 117 |
| Venous Thrombosis | 39 |
| Pulmonary Embolism | 33 |
| Thrombosis | 14 |
| Neoplasms | 12 |
| Thromboembolism | 12 |
| Atrial Fibrillation | 8 |
| Embolism and Thrombosis | 4 |
| Hemorrhage | 4 |
| Cardiovascular Diseases | 3 |
Trials
Showing 76 to 100 of 117. Each trial links to its page on Pharma Observatory.
17 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.